| ENPSX | RYCCX | ENPSX / RYCCX | |
| Total Expense Ratio | 2.65 | 2.50 | 106% |
| Annual Report Gross Expense Ratio | 2.65 | 2.62 | 101% |
| Fund Existence | 26 years | 26 years | - |
| Gain YTD | 58.820 | 32.591 | 180% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 15000 | 2500 | 600% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 62.7M | 1.68B | 4% |
| Annual Yield % from dividends | 1.35 | 0.00 | - |
| Returns for 1 year | 69.89 | 30.09 | 232% |
| Returns for 3 years | 56.31 | 143.36 | 39% |
| Returns for 5 years | 248.65 | 78.50 | 317% |
| Returns for 10 years | 87.61 | 755.02 | 12% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BRSPX | 16.66 | 0.11 | +0.66% |
| MFS Blended Research Small Cap Eq R1 | |||
| TWQIX | 20.30 | 0.04 | +0.20% |
| Transamerica Large Cap Value I | |||
| VPRDX | 7.58 | N/A | N/A |
| VY® Morgan Stanley Global Franchise R6 | |||
| THCVX | 34.68 | -0.01 | -0.03% |
| Nuveen Large Cap Value Idx I | |||
| FHJTX | 50.57 | -0.03 | -0.06% |
| Fidelity Advisor Europe C | |||